ROMIPLOSTIM

ROMIPLOSTIM was reported 15182 times

ROMIPLOSTIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RETICULIN INCREASED 17 0.4474
1 BONE MARROW RETICULIN FIBROSIS 115 0.4457
2 SPLENOSIS 8 0.4444
3 BIOPSY BONE MARROW ABNORMAL 89 0.1960
4 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 89 0.1939
5 MUCOCUTANEOUS HAEMORRHAGE 28 0.1879
6 PLATELET COUNT ABNORMAL 962 0.1590
7 LEUKOERYTHROBLASTIC ANAEMIA 6 0.1304
8 SPLENECTOMY 138 0.1188
9 MEGAKARYOCYTES INCREASED 14 0.1129
10 EVANS SYNDROME 51 0.1034
11 BLOOD SMEAR TEST ABNORMAL 8 0.1000
12 THROMBOCYTOSIS 341 0.0930
13 LEUKOERYTHROBLASTOSIS 7 0.0700
14 ANTIBODY TEST 5 0.0685
15 MESENTERIC VASCULAR INSUFFICIENCY 7 0.0636
16 MEGAKARYOCYTES ABNORMAL 7 0.0619
17 MYELOPROLIFERATIVE DISORDER 14 0.0579
18 ANTI-PLATELET ANTIBODY POSITIVE 10 0.0578
19 CELLULITIS GANGRENOUS 11 0.0558
20 ACCESSORY SPLEEN 5 0.0556
21 IDIOPATHIC THROMBOCYTOPENIC PURPURA 85 0.0538
22 MEGAKARYOCYTES DECREASED 5 0.0538
23 MYELOFIBROSIS 157 0.0519
24 PLATELET MORPHOLOGY ABNORMAL 7 0.0511
25 IMMUNE THROMBOCYTOPENIA 225 0.0491
26 NEUTRALISING ANTIBODIES 6 0.0476
27 THROMBOCYTOPENIA NEONATAL 20 0.0475
28 NUCLEATED RED CELLS 5 0.0446
29 NEUTRALISING ANTIBODIES POSITIVE 18 0.0431
30 MUCOSAL HAEMORRHAGE 44 0.0379
31 LYMPHADENITIS 91 0.0375
32 MARROW HYPERPLASIA 25 0.0367
33 PLATELET COUNT 20 0.0345
34 BONE MARROW MYELOGRAM ABNORMAL 6 0.0345
35 CHRONIC MYELOMONOCYTIC LEUKAEMIA 21 0.0318
36 PLATELET COUNT INCREASED 404 0.0310
37 ANGINA BULLOSA HAEMORRHAGICA 7 0.0302
38 ORAL BLOOD BLISTER 6 0.0300
39 EMBOLISM ARTERIAL 33 0.0275
40 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 12 0.0256
41 BLAST CELLS PRESENT 12 0.0249
42 PETECHIAE 253 0.0242
43 CEREBRAL VENOUS SINUS THROMBOSIS 19 0.0225
44 IMMUNE THROMBOCYTOPENIC PURPURA 61 0.0216
45 ANTIPHOSPHOLIPID SYNDROME 34 0.0211
46 MONOCYTOSIS 13 0.0209
47 LARGE GRANULAR LYMPHOCYTOSIS 7 0.0208
48 PLATELET DISORDER 51 0.0202
49 NON-HODGKIN'S LYMPHOMA 24 0.0183
50 HAEMATOLOGICAL MALIGNANCY 52 0.0183
51 BONE MARROW DISORDER 54 0.0179
52 BASAL GANGLIA INFARCTION 6 0.0174
53 MYELODYSPLASTIC SYNDROME 247 0.0171
54 PLATELET COUNT DECREASED 1778 0.0167
55 CEREBRAL VENOUS THROMBOSIS 30 0.0165
56 CARDIAC VALVE VEGETATION 8 0.0165
57 ERYTHROMELALGIA 6 0.0164
58 BLAST CELL COUNT INCREASED 17 0.0162
59 CHRONIC LYMPHOCYTIC LEUKAEMIA 77 0.0162
60 MULTIMORBIDITY 19 0.0159
61 HERPES SIMPLEX REACTIVATION 6 0.0157
62 THERAPEUTIC RESPONSE DECREASED 943 0.0155
63 HAEMOLYSIS 119 0.0154
64 HERPES SIMPLEX ENCEPHALITIS 7 0.0151
65 RENAL VEIN THROMBOSIS 10 0.0148
66 APLASTIC ANAEMIA 75 0.0143
67 PROTEIN-LOSING GASTROENTEROPATHY 7 0.0141
68 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 8 0.0138
69 MYELODYSPLASTIC SYNDROME TRANSFORMATION 7 0.0134
70 PORTAL VEIN THROMBOSIS 42 0.0130
71 INTERCEPTED PRODUCT ADMINISTRATION ERROR 99 0.0129
72 ECCHYMOSIS 88 0.0128
73 RED BLOOD CELL ABNORMALITY 12 0.0125
74 ANISOCYTOSIS 8 0.0122
75 MYELOPROLIFERATIVE NEOPLASM 8 0.0121
76 HAEMORRHAGIC DISORDER 13 0.0119
77 SPLENIC VEIN THROMBOSIS 6 0.0118
78 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0115
79 HAEMOPERITONEUM 9 0.0112
80 MOUTH HAEMORRHAGE 76 0.0104
81 MESENTERIC VEIN THROMBOSIS 10 0.0100
82 UPPER RESPIRATORY TRACT INFLAMMATION 12 0.0100
83 PURPURA 88 0.0099
84 MIGRAINE WITH AURA 27 0.0099
85 CEREBRAL ARTERY THROMBOSIS 5 0.0097
86 BLOOD BLISTER 30 0.0096
87 SUPERFICIAL VEIN THROMBOSIS 8 0.0095
88 THROMBOCYTOPENIA 1052 0.0094
89 INTRACRANIAL VENOUS SINUS THROMBOSIS 10 0.0093
90 PLATELET TRANSFUSION 12 0.0093
91 ARTERIAL THROMBOSIS 18 0.0093
92 ACUTE LEUKAEMIA 15 0.0093
93 BASOPHIL COUNT INCREASED 7 0.0092
94 INVESTIGATION 28 0.0089
95 ACUTE MYELOID LEUKAEMIA 135 0.0087
96 RETINAL VEIN THROMBOSIS 6 0.0086
97 THERAPEUTIC RESPONSE INCREASED 8 0.0085
98 BRAIN STEM HAEMORRHAGE 8 0.0085
99 ANAEMIA HAEMOLYTIC AUTOIMMUNE 7 0.0085
100 ANTIBODY TEST POSITIVE 14 0.0084
101 HAEMORRHAGIC DIATHESIS 30 0.0084
102 SPLEEN DISORDER 14 0.0083
103 CAROTID ARTERY THROMBOSIS 7 0.0082
104 EMBOLISM 68 0.0082
105 THROMBOTIC STROKE 6 0.0082
106 REFUSAL OF TREATMENT BY PATIENT 53 0.0081
107 CEREBELLAR HAEMORRHAGE 11 0.0077
108 GINGIVAL BLEEDING 105 0.0077
109 AUTOIMMUNE HAEMOLYTIC ANAEMIA 26 0.0076
110 IRON OVERLOAD 8 0.0074
111 VENOUS THROMBOSIS LIMB 15 0.0073
112 VIRAEMIA 10 0.0072
113 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 240 0.0071
114 SUBCLAVIAN VEIN THROMBOSIS 8 0.0070
115 ABDOMINAL LYMPHADENOPATHY 6 0.0069
116 BACTERIAL DISEASE CARRIER 5 0.0069
117 TRANSFUSION REACTION 6 0.0068
118 VENOUS THROMBOSIS 26 0.0066
119 VENA CAVA THROMBOSIS 11 0.0066
120 CONJUNCTIVAL HAEMORRHAGE 25 0.0065
121 PERIPHERAL ARTERY THROMBOSIS 9 0.0064
122 OVARIAN DISORDER 6 0.0064
123 THERAPY NON-RESPONDER 279 0.0062
124 DRUG EFFECT VARIABLE 7 0.0062
125 BRAIN HYPOXIA 6 0.0060
126 LOSS OF THERAPEUTIC RESPONSE 19 0.0060
127 DILATED CARDIOMYOPATHY 6 0.0059
128 SUDDEN HEARING LOSS 12 0.0059
129 B-CELL LYMPHOMA 20 0.0059
130 MULTIPLE MYELOMA 27 0.0058
131 SPLENIC INFARCTION 10 0.0057
132 THERAPEUTIC RESPONSE DELAYED 16 0.0057
133 NORMOCHROMIC NORMOCYTIC ANAEMIA 17 0.0057
134 SPLENOMEGALY 66 0.0056
135 CHRONIC MYELOID LEUKAEMIA 26 0.0056
136 JUGULAR VEIN THROMBOSIS 10 0.0056
137 COLON CANCER METASTATIC 9 0.0056
138 LYMPHOCYTOSIS 12 0.0056
139 HAEMORRHAGE INTRACRANIAL 80 0.0053
140 EMBOLISM VENOUS 16 0.0053
141 FIBROSIS 16 0.0052
142 THROMBOCYTOPENIC PURPURA 7 0.0051
143 DRUG SPECIFIC ANTIBODY 7 0.0051
144 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0051
145 OCCUPATIONAL EXPOSURE TO PRODUCT 32 0.0050
146 LEUKOCYTOSIS 88 0.0049
147 DEEP VEIN THROMBOSIS 309 0.0048
148 HYPERCOAGULATION 9 0.0047
149 ANAEMIA MACROCYTIC 10 0.0047
150 GENE MUTATION 9 0.0045
151 CYTOGENETIC ABNORMALITY 5 0.0044
152 BLOOD LOSS ANAEMIA 10 0.0044
153 POLYCYTHAEMIA 9 0.0044
154 EMBOLIC STROKE 15 0.0043
155 ESCHERICHIA BACTERAEMIA 10 0.0042
156 HAEMOLYTIC ANAEMIA 38 0.0042
157 BILE DUCT CANCER 5 0.0042
158 LUNG CANCER METASTATIC 12 0.0042
159 CARDIAC DEATH 5 0.0041
160 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
161 GLIOBLASTOMA 7 0.0041
162 PULMONARY HAEMORRHAGE 32 0.0041
163 LEUKAEMIA 38 0.0040
164 STEROID DIABETES 6 0.0040
165 INTERCEPTED PRODUCT PREPARATION ERROR 49 0.0040
166 THROMBOPHLEBITIS SUPERFICIAL 12 0.0040
167 PRODUCT PREPARATION ERROR 81 0.0039
168 PRODUCT STORAGE ERROR 345 0.0039
169 PERIPHERAL ISCHAEMIA 16 0.0039
170 LYMPHOMA 60 0.0039
171 ATRIAL THROMBOSIS 8 0.0039
172 EPISTAXIS 286 0.0038
173 NO THERAPEUTIC RESPONSE 46 0.0038
174 HAEMORRHAGE 391 0.0037
175 OROPHARYNGEAL BLISTERING 6 0.0037
176 PERICARDIAL HAEMORRHAGE 8 0.0037
177 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
178 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 8 0.0036
179 PORTAL HYPERTENSION 11 0.0036
180 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
181 LEUKAEMIA RECURRENT 6 0.0035
182 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 5 0.0035
183 LAZINESS 6 0.0035
184 APLASIA PURE RED CELL 12 0.0035
185 INTERCEPTED MEDICATION ERROR 16 0.0034
186 THERAPEUTIC PRODUCT EFFECT DECREASED 154 0.0034
187 CUSHINGOID 11 0.0034
188 HAEMOGLOBIN ABNORMAL 22 0.0034
189 BACTERIAL SEPSIS 11 0.0034
190 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
191 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
192 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 7 0.0033
193 MANTLE CELL LYMPHOMA 5 0.0033
194 RENAL FAILURE CHRONIC 25 0.0032
195 GRAFT VERSUS HOST DISEASE 23 0.0032
196 SYSTEMIC CANDIDA 8 0.0032
197 CEREBRAL THROMBOSIS 9 0.0032
198 CHEMOTHERAPY 12 0.0032
199 CYTOMEGALOVIRUS INFECTION REACTIVATION 14 0.0032
200 AORTIC STENOSIS 11 0.0032
201 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
202 HAEMATOMA 81 0.0031
203 CONTUSION 297 0.0031
204 VENTRICULAR DYSFUNCTION 8 0.0031
205 APLASIA 6 0.0031
206 PULMONARY EMBOLISM 291 0.0031
207 BICYTOPENIA 6 0.0031
208 HEPATIC CIRRHOSIS 57 0.0030
209 ISCHAEMIC STROKE 54 0.0030
210 ACUTE CORONARY SYNDROME 25 0.0030
211 HEAVY MENSTRUAL BLEEDING 27 0.0030
212 MELAENA 66 0.0030
213 WHITE BLOOD CELL COUNT INCREASED 115 0.0030
214 EAR HAEMORRHAGE 6 0.0030
215 INCREASED TENDENCY TO BRUISE 27 0.0029
216 PRODUCT LABEL CONFUSION 17 0.0029
217 URINARY BLADDER HAEMORRHAGE 6 0.0028
218 EYE CONTUSION 6 0.0028
219 HEPATIC NEOPLASM MALIGNANT 6 0.0028
220 NEUTROPHIL COUNT ABNORMAL 8 0.0028
221 CEREBRAL HAEMORRHAGE 101 0.0028
222 THERAPY PARTIAL RESPONDER 44 0.0028
223 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
224 URINARY TRACT INFECTION BACTERIAL 7 0.0028
225 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
226 HYPOGAMMAGLOBULINAEMIA 18 0.0027
227 LYMPHOPROLIFERATIVE DISORDER 8 0.0027
228 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
229 LIVING IN RESIDENTIAL INSTITUTION 5 0.0027
230 PAPILLOEDEMA 12 0.0027
231 SUBDURAL HAEMATOMA 38 0.0027
232 DRUG EFFECT DELAYED 12 0.0026
233 VARICES OESOPHAGEAL 8 0.0026
234 BONE MARROW TRANSPLANT 5 0.0026
235 ACUTE MYOCARDIAL INFARCTION 77 0.0026
236 LYMPHADENOPATHY MEDIASTINAL 5 0.0026
237 ISCHAEMIC CARDIOMYOPATHY 8 0.0026
238 REHABILITATION THERAPY 10 0.0026
239 HOSPITALISATION 394 0.0026
240 SUBDURAL HAEMORRHAGE 7 0.0026
241 CELL DEATH 5 0.0025
242 EMPYEMA 5 0.0025
243 SERUM SICKNESS 7 0.0025
244 FAILURE TO THRIVE 13 0.0025
245 CORONARY ARTERY THROMBOSIS 5 0.0025
246 PANCREATIC CARCINOMA METASTATIC 7 0.0025
247 IRON DEFICIENCY 11 0.0024
248 ACUTE RESPIRATORY DISTRESS SYNDROME 43 0.0024
249 SKIN HAEMORRHAGE 36 0.0024
250 ENTEROCOLITIS 14 0.0024
251 HAEMOTHORAX 7 0.0024
252 HAEMOGLOBIN INCREASED 11 0.0024
253 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 70 0.0024
254 IRON DEFICIENCY ANAEMIA 22 0.0024
255 BONE MARROW FAILURE 48 0.0024
256 HAEMORRHAGE URINARY TRACT 6 0.0024
257 SUBARACHNOID HAEMORRHAGE 24 0.0024
258 WHITE BLOOD CELL COUNT ABNORMAL 15 0.0023
259 PHLEBITIS 12 0.0023
260 MALNUTRITION 26 0.0023
261 HIV INFECTION 7 0.0023
262 POST PROCEDURAL HAEMORRHAGE 27 0.0023
263 DRUG SPECIFIC ANTIBODY PRESENT 15 0.0023
264 THROMBOPHLEBITIS 8 0.0023
265 THROMBOSIS 183 0.0023
266 THROMBOTIC THROMBOCYTOPENIC PURPURA 8 0.0023
267 HAEMORRHAGE SUBCUTANEOUS 8 0.0023
268 TERMINAL STATE 15 0.0022
269 HAEMATOCRIT INCREASED 5 0.0022
270 DRUG EFFECT DECREASED 118 0.0022
271 RED BLOOD CELL COUNT INCREASED 6 0.0022
272 HEPATITIS CHOLESTATIC 13 0.0022
273 IMMUNOSUPPRESSION 19 0.0022
274 LUNG NEOPLASM 9 0.0021
275 HAEMATURIA 72 0.0021
276 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
277 PANCYTOPENIA 116 0.0021
278 ADENOVIRUS INFECTION 6 0.0021
279 PNEUMONIA FUNGAL 8 0.0020
280 BACTERAEMIA 24 0.0020
281 GASTROINTESTINAL HAEMORRHAGE 169 0.0020
282 CAROTID ARTERY STENOSIS 7 0.0020
283 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
284 PRODUCT PREPARATION ISSUE 13 0.0020
285 RASH MACULO-PAPULAR 44 0.0020
286 ISCHAEMIA 9 0.0020
287 NEUTROPHIL COUNT INCREASED 20 0.0020
288 HEPATOSPLENOMEGALY 5 0.0019
289 MEAN CELL VOLUME INCREASED 5 0.0019
290 PRODUCT TEMPERATURE EXCURSION ISSUE 10 0.0019
291 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 5 0.0019
292 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
293 NEUTROPHILIA 11 0.0019
294 SCLERODERMA 7 0.0019
295 INTERNAL HAEMORRHAGE 22 0.0019
296 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
297 CORONARY ARTERY BYPASS 11 0.0019
298 SEPSIS 213 0.0019
299 HEPATITIS C 23 0.0019
300 STRESS CARDIOMYOPATHY 11 0.0019
301 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
302 RECTAL HAEMORRHAGE 81 0.0019
303 HYPOVOLAEMIC SHOCK 9 0.0019
304 PLEURAL EFFUSION 114 0.0019
305 ATELECTASIS 18 0.0019
306 METASTATIC NEOPLASM 8 0.0019
307 THROMBOTIC MICROANGIOPATHY 18 0.0018
308 HERPES SIMPLEX 12 0.0018
309 HEPATIC ENZYME INCREASED 125 0.0018
310 HOSPICE CARE 18 0.0018
311 HEPATIC ENCEPHALOPATHY 17 0.0018
312 BONE PAIN 106 0.0018
313 RHINOVIRUS INFECTION 7 0.0018
314 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
315 MUSCULOSKELETAL PAIN 94 0.0018
316 PROCEDURAL HAEMORRHAGE 7 0.0018
317 ENDOTRACHEAL INTUBATION 5 0.0018
318 CLOSTRIDIAL INFECTION 6 0.0018
319 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
320 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
321 VIRAL INFECTION 58 0.0017
322 ORGAN FAILURE 7 0.0017
323 CYSTITIS HAEMORRHAGIC 7 0.0017
324 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 95 0.0017
325 HYPERTRANSAMINASAEMIA 12 0.0017
326 ESCHERICHIA SEPSIS 5 0.0017
327 TRANSFUSION 18 0.0017
328 HYPOVOLAEMIA 10 0.0017
329 DRUG EFFECT INCOMPLETE 62 0.0017
330 ANGINA UNSTABLE 11 0.0017
331 RETINAL HAEMORRHAGE 12 0.0017
332 BRAIN HERNIATION 5 0.0017
333 HYPOALBUMINAEMIA 13 0.0017
334 BLOOD CULTURE POSITIVE 5 0.0017
335 RENAL TRANSPLANT 6 0.0017
336 TRANSIENT ISCHAEMIC ATTACK 56 0.0017
337 MONOCYTE COUNT INCREASED 6 0.0017
338 LIVER TRANSPLANT 6 0.0016
339 ABSCESS LIMB 7 0.0016
340 BLOOD ALBUMIN DECREASED 13 0.0016
341 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
342 VAGINAL HAEMORRHAGE 71 0.0016
343 MIGRAINE 156 0.0016
344 INTRACARDIAC THROMBUS 5 0.0016
345 HEPATOMEGALY 16 0.0016
346 OVARIAN CANCER 15 0.0016
347 UNEVALUABLE EVENT 123 0.0016
348 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
349 WOUND HAEMORRHAGE 6 0.0016
350 LABORATORY TEST ABNORMAL 47 0.0016
351 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
352 NEUTROPENIA 214 0.0016
353 HAEMOGLOBIN DECREASED 161 0.0016
354 MULTI-ORGAN FAILURE 27 0.0016
355 PULMONARY THROMBOSIS 17 0.0016
356 CEREBRAL INFARCTION 38 0.0016
357 CEREBRAL ISCHAEMIA 8 0.0016
358 SUSPECTED OFF LABEL USE 7 0.0015
359 CANDIDA INFECTION 26 0.0015
360 RED BLOOD CELL COUNT DECREASED 44 0.0015
361 PROSTATOMEGALY 6 0.0015
362 HAEMATOCRIT DECREASED 30 0.0015
363 EXPOSURE VIA BREAST MILK 6 0.0015
364 MENINGITIS 10 0.0015
365 CANDIDIASIS 6 0.0015
366 ANAEMIA 282 0.0015
367 COLON CANCER 22 0.0015
368 PRE-ECLAMPSIA 7 0.0015
369 LUNG INFILTRATION 13 0.0015
370 HYDRONEPHROSIS 11 0.0015
371 GOITRE 6 0.0015
372 OFF LABEL USE 1282 0.0015
373 INFUSION RELATED REACTION 97 0.0015
374 ASCITES 43 0.0015
375 CAESAREAN SECTION 17 0.0015
376 INTESTINAL ISCHAEMIA 8 0.0015
377 IMMUNE SYSTEM DISORDER 19 0.0014
378 INTERMENSTRUAL BLEEDING 8 0.0014
379 SEPTIC SHOCK 62 0.0014
380 UROSEPSIS 13 0.0014
381 HAEMORRHAGIC STROKE 11 0.0014
382 FIBRIN D DIMER INCREASED 5 0.0014
383 VEIN DISORDER 7 0.0014
384 CARDIAC OPERATION 12 0.0014
385 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
386 BLOOD DISORDER 11 0.0014
387 DIVERTICULUM INTESTINAL 6 0.0014
388 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
389 SYSTEMIC LUPUS ERYTHEMATOSUS 48 0.0014
390 ACUTE RESPIRATORY FAILURE 26 0.0014
391 SHOCK HAEMORRHAGIC 11 0.0013
392 DECUBITUS ULCER 11 0.0013
393 RESPIRATORY FAILURE 98 0.0013
394 DRUG INEFFECTIVE 1769 0.0013
395 PROTHROMBIN TIME PROLONGED 8 0.0013
396 AUTOIMMUNE THYROIDITIS 5 0.0013
397 PREMATURE DELIVERY 21 0.0013
398 NEPHROTIC SYNDROME 9 0.0013
399 PNEUMONIA BACTERIAL 12 0.0013
400 CYTOPENIA 16 0.0013
401 ANAL ABSCESS 7 0.0013
402 HEMIPARESIS 22 0.0013
403 NORMAL NEWBORN 7 0.0013
404 PERFORMANCE STATUS DECREASED 6 0.0013
405 NEUTROPENIC SEPSIS 9 0.0013
406 CEREBROVASCULAR ACCIDENT 212 0.0013
407 RENAL FAILURE ACUTE 53 0.0012
408 ACUTE PULMONARY OEDEMA 7 0.0012
409 MUSCLE HAEMORRHAGE 5 0.0012
410 ENTEROCOCCAL INFECTION 6 0.0012
411 SUDDEN DEATH 13 0.0012
412 HYPERURICAEMIA 5 0.0012
413 TREATMENT FAILURE 100 0.0012
414 TOOTH EXTRACTION 15 0.0012
415 CYTOMEGALOVIRUS INFECTION 20 0.0012
416 VASCULITIS 14 0.0012
417 EOSINOPHIL COUNT INCREASED 10 0.0012
418 CORONARY ARTERY STENOSIS 6 0.0012
419 DEATH 1019 0.0012
420 OEDEMA PERIPHERAL 144 0.0012
421 SINUS HEADACHE 7 0.0012
422 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
423 MENORRHAGIA 23 0.0012
424 ENDOCARDITIS 6 0.0012
425 CACHEXIA 6 0.0012
426 TONSILLITIS 6 0.0011
427 HAEMORRHAGIC ANAEMIA 5 0.0011
428 DUODENAL ULCER 8 0.0011
429 ABDOMINAL ABSCESS 5 0.0011
430 GASTRIC HAEMORRHAGE 13 0.0011
431 COMPRESSION FRACTURE 6 0.0011
432 CARDIOGENIC SHOCK 16 0.0011
433 COVID-19 PNEUMONIA 13 0.0011
434 DISEASE COMPLICATION 5 0.0011
435 CHOLECYSTITIS 13 0.0011
436 METASTASES TO CENTRAL NERVOUS SYSTEM 14 0.0011
437 LOCALISED OEDEMA 5 0.0011
438 INFECTION 156 0.0011
439 SURGERY 63 0.0011
440 MACULAR OEDEMA 6 0.0011
441 LACERATION 10 0.0011
442 PNEUMONIA 343 0.0011
443 CARDIAC FAILURE 85 0.0011
444 ENCEPHALOPATHY 26 0.0011
445 MATERNAL EXPOSURE DURING PREGNANCY 94 0.0011
446 NEUROLOGICAL SYMPTOM 6 0.0010
447 PHARYNGITIS 13 0.0010
448 MYOCARDITIS 12 0.0010
449 NEOPLASM 12 0.0010
450 SKIN ATROPHY 6 0.0010
451 HERPES VIRUS INFECTION 6 0.0010
452 MYALGIA 177 0.0010
453 TRANSAMINASES INCREASED 23 0.0010
454 GUILLAIN-BARRE SYNDROME 5 0.0010
455 VITAMIN D DEFICIENCY 10 0.0010
456 BREAST CANCER METASTATIC 11 0.0010
457 INCORRECT DOSAGE ADMINISTERED 5 0.0010
458 CARDIOMYOPATHY 15 0.0010
459 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
460 BLOOD IRON DECREASED 12 0.0010
461 DIABETIC NEUROPATHY 5 0.0010
462 RENAL CYST 8 0.0010
463 RASH ERYTHEMATOUS 48 0.0010
464 RESPIRATORY TRACT INFECTION 26 0.0010
465 GANGRENE 6 0.0010
466 HEPATIC FAILURE 30 0.0010
467 HERPES ZOSTER 57 0.0010
468 LYMPHOPENIA 14 0.0010
469 DIALYSIS 14 0.0010
470 INGUINAL HERNIA 6 0.0010
471 HEADACHE 616 0.0010
472 DIVERTICULITIS 27 0.0010
473 LUNG NEOPLASM MALIGNANT 40 0.0010
474 PIGMENTATION DISORDER 6 0.0010
475 QUALITY OF LIFE DECREASED 13 0.0010
476 AGRANULOCYTOSIS 18 0.0010
477 SPINAL COMPRESSION FRACTURE 8 0.0010
478 BACTERIAL INFECTION 18 0.0010
479 FEBRILE NEUTROPENIA 64 0.0010
480 COAGULOPATHY 16 0.0010
481 NEOPLASM MALIGNANT 64 0.0010
482 INTENTIONAL PRODUCT MISUSE 83 0.0009
483 DRUG EFFECT LESS THAN EXPECTED 14 0.0009
484 NYSTAGMUS 5 0.0009
485 LYMPHADENOPATHY 33 0.0009
486 DEMENTIA 26 0.0009
487 PREMATURE BABY 28 0.0009
488 BEHAVIOUR DISORDER 5 0.0009
489 ATRIAL FIBRILLATION 90 0.0009
490 CARDIAC FAILURE CONGESTIVE 74 0.0009
491 TROPONIN INCREASED 7 0.0009
492 KNEE OPERATION 9 0.0009
493 HEPATIC FUNCTION ABNORMAL 34 0.0009
494 WALKING AID USER 6 0.0009
495 STAPHYLOCOCCAL INFECTION 30 0.0009
496 BLOOD PRESSURE ABNORMAL 18 0.0009
497 ADVERSE EVENT 83 0.0009
498 CYTOKINE RELEASE SYNDROME 18 0.0009
499 MALIGNANT MELANOMA 12 0.0009
500 CARDIOMEGALY 11 0.0009
501 ANGIOPATHY 5 0.0009
502 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
503 ARTERIAL OCCLUSIVE DISEASE 7 0.0009
504 GENERALISED OEDEMA 11 0.0009
505 POST PROCEDURAL COMPLICATION 17 0.0009
506 TRICUSPID VALVE INCOMPETENCE 7 0.0009
507 INFARCTION 6 0.0009
508 CELLULITIS 44 0.0009
509 HAEMORRHOIDS 17 0.0009
510 HYPERBILIRUBINAEMIA 9 0.0009
511 STENT PLACEMENT 7 0.0009
512 BLOOD GLUCOSE ABNORMAL 16 0.0009
513 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
514 METABOLIC DISORDER 5 0.0009
515 ARTHRALGIA 358 0.0009
516 LIVER FUNCTION TEST ABNORMAL 25 0.0009
517 DRUG RESISTANCE 22 0.0009
518 HYPOXIA 30 0.0009
519 BLOOD BILIRUBIN INCREASED 23 0.0009
520 OEDEMA 46 0.0008
521 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
522 DIVERTICULUM 6 0.0008
523 NEUROPATHY PERIPHERAL 80 0.0008
524 DISEASE RECURRENCE 40 0.0008
525 PNEUMONIA ASPIRATION 21 0.0008
526 LIVER DISORDER 37 0.0008
527 HEPATITIS B 5 0.0008
528 ADVERSE REACTION 11 0.0008
529 MENTAL STATUS CHANGES 23 0.0008
530 CORONARY ARTERY DISEASE 25 0.0008
531 EYE HAEMORRHAGE 11 0.0008
532 GASTROENTERITIS 12 0.0008
533 FACIAL PARALYSIS 7 0.0008
534 UTERINE LEIOMYOMA 6 0.0008
535 AUTOIMMUNE DISORDER 8 0.0008
536 DISEASE PROGRESSION 97 0.0008
537 THERAPY CHANGE 8 0.0008
538 MENISCUS INJURY 5 0.0008
539 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
540 CHOLANGITIS 5 0.0008
541 RENAL FAILURE 107 0.0008
542 TREATMENT NONCOMPLIANCE 44 0.0008
543 SKIN INFECTION 9 0.0008
544 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
545 ABDOMINAL PAIN 186 0.0008
546 CARDIAC ARREST 66 0.0008
547 GASTRITIS 21 0.0008
548 EYE INFECTION 9 0.0008
549 HYPERGLYCAEMIA 29 0.0008
550 BRAIN OEDEMA 10 0.0008
551 MYOCARDIAL ISCHAEMIA 9 0.0008
552 HAEMOPTYSIS 22 0.0008
553 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 41 0.0008
554 NEUTROPHIL COUNT DECREASED 32 0.0008
555 PULMONARY FIBROSIS 15 0.0008
556 ASTHENIA 294 0.0008
557 JAUNDICE 21 0.0008
558 METASTASES TO LUNG 9 0.0008
559 PERICARDIAL EFFUSION 18 0.0008
560 CONSTIPATION 168 0.0008
561 DYSPNOEA EXERTIONAL 29 0.0008
562 PULMONARY HYPERTENSION 16 0.0008
563 ASPERGILLUS INFECTION 5 0.0008
564 FLUID OVERLOAD 11 0.0008
565 CARDIAC FAILURE ACUTE 5 0.0007
566 FLANK PAIN 7 0.0007
567 LOCALISED INFECTION 18 0.0007
568 RHINITIS 6 0.0007
569 ARTERIOSCLEROSIS 7 0.0007
570 BRONCHIECTASIS 5 0.0007
571 MYOCARDIAL INFARCTION 129 0.0007
572 PULMONARY MASS 11 0.0007
573 POST PROCEDURAL INFECTION 6 0.0007
574 BLOOD URINE PRESENT 14 0.0007
575 BODY TEMPERATURE INCREASED 15 0.0007
576 ASPHYXIA 6 0.0007
577 SMALL INTESTINAL OBSTRUCTION 9 0.0007
578 METASTASES TO BONE 12 0.0007
579 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 52 0.0007
580 PAIN IN EXTREMITY 214 0.0007
581 CYST 9 0.0007
582 GOUT 13 0.0007
583 DIZZINESS POSTURAL 7 0.0007
584 VENTRICULAR FIBRILLATION 8 0.0007
585 AUTOIMMUNE HEPATITIS 5 0.0007
586 HYPOMAGNESAEMIA 10 0.0007
587 CARDIO-RESPIRATORY ARREST 30 0.0007
588 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
589 DIABETES MELLITUS 54 0.0007
590 REBOUND EFFECT 8 0.0007
591 LEUKOPENIA 35 0.0007
592 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
593 MYOPATHY 6 0.0007
594 PRODUCT PRESCRIBING ISSUE 15 0.0007
595 MUSCULAR WEAKNESS 78 0.0007
596 PARAESTHESIA 107 0.0007
597 HYPOPHOSPHATAEMIA 5 0.0007
598 HEPATOTOXICITY 15 0.0007
599 CHOLELITHIASIS 22 0.0007
600 HYPERLIPIDAEMIA 8 0.0007
601 POLYNEUROPATHY 8 0.0007
602 ADVERSE DRUG REACTION 60 0.0007
603 HYPERTENSION 141 0.0007
604 FULL BLOOD COUNT ABNORMAL 7 0.0007
605 PYREXIA 229 0.0007
606 BLOOD COUNT ABNORMAL 10 0.0007
607 ADRENAL INSUFFICIENCY 8 0.0007
608 AORTIC ANEURYSM 5 0.0007
609 GENERAL PHYSICAL HEALTH DETERIORATION 76 0.0007
610 ACCIDENTAL EXPOSURE TO PRODUCT 67 0.0006
611 DEVICE RELATED INFECTION 10 0.0006
612 ILEUS 8 0.0006
613 BLOOD TEST ABNORMAL 9 0.0006
614 INTERSTITIAL LUNG DISEASE 31 0.0006
615 OSTEONECROSIS 21 0.0006
616 PROTEINURIA 12 0.0006
617 HAEMATEMESIS 16 0.0006
618 LOW BIRTH WEIGHT BABY 5 0.0006
619 PALLOR 17 0.0006
620 PANCREATITIS 33 0.0006
621 DYSPEPSIA 61 0.0006
622 RASH GENERALISED 16 0.0006
623 HIATUS HERNIA 8 0.0006
624 URINARY TRACT INFECTION 105 0.0006
625 FATIGUE 479 0.0006
626 SCAB 7 0.0006
627 CARDIAC DISORDER 57 0.0006
628 ESCHERICHIA INFECTION 5 0.0006
629 RENAL IMPAIRMENT 51 0.0006
630 LIVER FUNCTION TEST INCREASED 13 0.0006
631 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 43 0.0006
632 INFLUENZA 67 0.0006
633 OVARIAN CYST 6 0.0006
634 FUNGAL INFECTION 20 0.0006
635 HYPERKALAEMIA 21 0.0006
636 EMPHYSEMA 6 0.0006
637 WHITE BLOOD CELL COUNT DECREASED 64 0.0006
638 LIMB INJURY 16 0.0006
639 MACULAR DEGENERATION 7 0.0006
640 INSOMNIA 156 0.0006
641 ASPARTATE AMINOTRANSFERASE INCREASED 31 0.0006
642 RASH PAPULAR 13 0.0006
643 RESPIRATORY DISTRESS 16 0.0006
644 LUNG INFECTION 9 0.0006
645 MUSCLE STRAIN 5 0.0006
646 HYSTERECTOMY 5 0.0006
647 TENDERNESS 6 0.0006
648 NEOPLASM PROGRESSION 20 0.0006
649 WEIGHT FLUCTUATION 6 0.0006
650 CARPAL TUNNEL SYNDROME 8 0.0006
651 EOSINOPHILIA 10 0.0006
652 GROIN PAIN 5 0.0006
653 METASTASES TO LIVER 10 0.0006
654 SPINAL OPERATION 7 0.0006
655 PNEUMOTHORAX 9 0.0006
656 DRUG ERUPTION 10 0.0006
657 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
658 ORAL HERPES 11 0.0006
659 CHILLS 66 0.0006
660 HAEMATOCHEZIA 31 0.0006
661 ILL-DEFINED DISORDER 34 0.0006
662 BACK PAIN 129 0.0006
663 GASTROENTERITIS VIRAL 10 0.0006
664 BACK DISORDER 9 0.0006
665 TOOTHACHE 10 0.0006
666 BONE DISORDER 10 0.0005
667 ASPIRATION 6 0.0005
668 FULL BLOOD COUNT DECREASED 11 0.0005
669 PRODUCT PRESCRIBING ERROR 13 0.0005
670 THERAPY INTERRUPTED 39 0.0005
671 NERVE COMPRESSION 5 0.0005
672 PROCEDURAL PAIN 15 0.0005
673 HYPERTENSIVE CRISIS 6 0.0005
674 DRUG DOSE OMISSION 89 0.0005
675 ALANINE AMINOTRANSFERASE INCREASED 33 0.0005
676 NASOPHARYNGITIS 99 0.0005
677 HEPATIC STEATOSIS 10 0.0005
678 MALAISE 235 0.0005
679 DIARRHOEA HAEMORRHAGIC 5 0.0005
680 HYPOAESTHESIA 80 0.0005
681 TOOTH INFECTION 7 0.0005
682 FOETAL EXPOSURE DURING PREGNANCY 43 0.0005
683 MOBILITY DECREASED 38 0.0005
684 MUSCULOSKELETAL DISORDER 10 0.0005
685 CHOLECYSTECTOMY 6 0.0005
686 VERTIGO 32 0.0005
687 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
688 HIP ARTHROPLASTY 8 0.0005
689 SKIN DISCOLOURATION 24 0.0005
690 MOUTH ULCERATION 11 0.0005
691 HYPOKALAEMIA 24 0.0005
692 ACUTE HEPATIC FAILURE 7 0.0005
693 SKIN CANCER 11 0.0005
694 ARTHRITIS 40 0.0005
695 RESPIRATORY ARREST 14 0.0005
696 CATARACT 30 0.0005
697 SCIATICA 8 0.0005
698 ABSCESS 8 0.0005
699 WOUND 14 0.0005
700 HIP FRACTURE 16 0.0005
701 SKIN REACTION 7 0.0005
702 MUCOSAL INFLAMMATION 13 0.0005
703 TOOTH DISORDER 11 0.0005
704 LETHARGY 28 0.0005
705 RASH MACULAR 17 0.0005
706 CONJUNCTIVITIS 9 0.0005
707 MENTAL DISORDER 21 0.0005
708 INJECTION SITE HAEMATOMA 7 0.0005
709 ABDOMINAL DISTENSION 50 0.0005
710 FRACTURE 9 0.0005
711 DIZZINESS 236 0.0005
712 IMMUNODEFICIENCY 7 0.0005
713 DIARRHOEA 303 0.0005
714 SLEEP DISORDER 33 0.0005
715 UNRESPONSIVE TO STIMULI 12 0.0005
716 PRURITUS GENERALISED 10 0.0005
717 DYSURIA 17 0.0005
718 FAECES DISCOLOURED 10 0.0005
719 GASTROINTESTINAL DISORDER 41 0.0005
720 COVID-19 80 0.0005
721 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
722 ANGINA PECTORIS 13 0.0005
723 MUSCULOSKELETAL CHEST PAIN 7 0.0005
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
725 PANCREATIC CARCINOMA 13 0.0004
726 SKIN DISORDER 15 0.0004
727 BASAL CELL CARCINOMA 7 0.0004
728 GALLBLADDER DISORDER 8 0.0004
729 INCORRECT ROUTE OF DRUG ADMINISTRATION 16 0.0004
730 INTESTINAL PERFORATION 5 0.0004
731 NAUSEA 352 0.0004
732 RASH PRURITIC 24 0.0004
733 OSTEOMYELITIS 8 0.0004
734 TACHYPNOEA 6 0.0004
735 PNEUMONITIS 12 0.0004
736 OBESITY 7 0.0004
737 FALL 146 0.0004
738 HYPOTHYROIDISM 14 0.0004
739 OSTEOPOROSIS 18 0.0004
740 INFLUENZA LIKE ILLNESS 36 0.0004
741 CHEST PAIN 81 0.0004
742 PERIPHERAL COLDNESS 6 0.0004
743 PERITONITIS 9 0.0004
744 NIGHT SWEATS 14 0.0004
745 ELECTROLYTE IMBALANCE 5 0.0004
746 HYPOPHAGIA 11 0.0004
747 DERMATITIS 9 0.0004
748 VENTRICULAR TACHYCARDIA 7 0.0004
749 DIPLOPIA 11 0.0004
750 EATING DISORDER 9 0.0004
751 SINUS TACHYCARDIA 6 0.0004
752 CONVULSION 24 0.0004
753 PARALYSIS 6 0.0004
754 BRONCHITIS 31 0.0004
755 HYPERSOMNIA 12 0.0004
756 CHOLESTASIS 8 0.0004
757 MEDICATION ERROR 23 0.0004
758 HERNIA 8 0.0004
759 FLUID RETENTION 21 0.0004
760 C-REACTIVE PROTEIN INCREASED 15 0.0004
761 WEIGHT DECREASED 115 0.0004
762 NOCTURIA 5 0.0004
763 NECK PAIN 23 0.0004
764 FIBROMYALGIA 10 0.0004
765 NEURALGIA 10 0.0004
766 DISCOMFORT 25 0.0004
767 MUSCLE SPASMS 75 0.0004
768 RENAL DISORDER 19 0.0004
769 INJECTION SITE EXTRAVASATION 5 0.0004
770 HYPERCALCAEMIA 5 0.0004
771 PULMONARY OEDEMA 18 0.0004
772 LOCAL SWELLING 7 0.0004
773 ARRHYTHMIA 19 0.0004
774 PREGNANCY 8 0.0004
775 HYPOTENSION 80 0.0004
776 DYSARTHRIA 15 0.0004
777 HYPOAESTHESIA ORAL 6 0.0004
778 DERMATITIS ALLERGIC 5 0.0004
779 RASH 173 0.0004
780 DECREASED APPETITE 92 0.0004
781 LYMPHOCYTE COUNT DECREASED 7 0.0004
782 BLOOD PRESSURE INCREASED 60 0.0004
783 RIB FRACTURE 8 0.0004
784 TENDONITIS 6 0.0004
785 PROSTATE CANCER 31 0.0004
786 RESTLESS LEGS SYNDROME 7 0.0004
787 BRAIN FOG 6 0.0004
788 DRUG-INDUCED LIVER INJURY 12 0.0004
789 DEAFNESS 10 0.0004
790 INCORRECT PRODUCT STORAGE 5 0.0004
791 BEDRIDDEN 5 0.0004
792 STOMATITIS 23 0.0004
793 FEELING HOT 23 0.0004
794 DRUG INTOLERANCE 36 0.0004
795 CONFUSIONAL STATE 60 0.0004
796 INFLAMMATION 19 0.0004
797 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
798 EYE DISORDER 12 0.0004
799 CORONARY ARTERY OCCLUSION 5 0.0004
800 SKIN LESION 10 0.0004
801 PHOTOSENSITIVITY REACTION 6 0.0004
802 DYSPNOEA 205 0.0004
803 EAR PAIN 7 0.0004
804 SYNCOPE 36 0.0004
805 PLASMA CELL MYELOMA 14 0.0004
806 ORAL PAIN 8 0.0004
807 COUGH 100 0.0004
808 ACCIDENTAL OVERDOSE 13 0.0004
809 FEELING ABNORMAL 85 0.0004
810 ABDOMINAL PAIN UPPER 73 0.0004
811 SINUS DISORDER 7 0.0004
812 DISORIENTATION 14 0.0004
813 BLOOD CREATININE INCREASED 23 0.0004
814 METRORRHAGIA 6 0.0004
815 HEPATITIS 9 0.0004
816 TACHYCARDIA 31 0.0003
817 HYPOACUSIS 15 0.0003
818 TINNITUS 16 0.0003
819 CYSTITIS 11 0.0003
820 TASTE DISORDER 7 0.0003
821 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
822 VOMITING 161 0.0003
823 ARTHROPATHY 19 0.0003
824 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
825 SWELLING FACE 22 0.0003
826 HYPONATRAEMIA 19 0.0003
827 FLATULENCE 19 0.0003
828 WEIGHT INCREASED 75 0.0003
829 OROPHARYNGEAL PAIN 31 0.0003
830 MYELOSUPPRESSION 12 0.0003
831 PRESYNCOPE 8 0.0003
832 IMPAIRED WORK ABILITY 7 0.0003
833 PAIN 200 0.0003
834 POOR QUALITY SLEEP 7 0.0003
835 ABORTION SPONTANEOUS 13 0.0003
836 ABASIA 8 0.0003
837 FEELING COLD 9 0.0003
838 LIMB DISCOMFORT 10 0.0003
839 AMNESIA 21 0.0003
840 EXPOSURE DURING PREGNANCY 20 0.0003
841 BLINDNESS 13 0.0003
842 PHOTOPHOBIA 6 0.0003
843 CYANOSIS 5 0.0003
844 DELIRIUM 11 0.0003
845 HEAD INJURY 10 0.0003
846 ALOPECIA 62 0.0003
847 GASTRIC ULCER 6 0.0003
848 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
849 PRODUCTIVE COUGH 15 0.0003
850 ABDOMINAL DISCOMFORT 52 0.0003
851 MUSCLE TIGHTNESS 5 0.0003
852 GAIT DISTURBANCE 59 0.0003
853 CHOKING 6 0.0003
854 VISUAL IMPAIRMENT 38 0.0003
855 NASAL CONGESTION 18 0.0003
856 LUNG DISORDER 15 0.0003
857 IMPAIRED HEALING 10 0.0003
858 DISABILITY 6 0.0003
859 SPINAL FRACTURE 6 0.0003
860 VISION BLURRED 41 0.0003
861 APHASIA 9 0.0003
862 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 60 0.0003
863 FEEDING DISORDER 6 0.0003
864 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
865 ACUTE KIDNEY INJURY 45 0.0003
866 MENTAL IMPAIRMENT 7 0.0003
867 ERYTHEMA 59 0.0003
868 ROAD TRAFFIC ACCIDENT 12 0.0003
869 BURNING SENSATION 20 0.0003
870 SINUSITIS 29 0.0003
871 HEART RATE INCREASED 28 0.0003
872 PAIN IN JAW 8 0.0003
873 INTENTIONAL DOSE OMISSION 8 0.0003
874 URTICARIA 47 0.0003
875 RHINORRHOEA 18 0.0003
876 DEHYDRATION 37 0.0003
877 HYPERSENSITIVITY 51 0.0003
878 END STAGE RENAL DISEASE 5 0.0003
879 LOSS OF CONSCIOUSNESS 35 0.0003
880 BLISTER 15 0.0003
881 JOINT STIFFNESS 7 0.0003
882 FLUSHING 27 0.0003
883 COLITIS 10 0.0003
884 MALIGNANT NEOPLASM PROGRESSION 27 0.0003
885 EAR INFECTION 7 0.0003
886 FEELING JITTERY 5 0.0003
887 CONDITION AGGRAVATED 79 0.0003
888 GLAUCOMA 5 0.0003
889 INCORRECT DOSE ADMINISTERED 59 0.0003
890 NERVOUS SYSTEM DISORDER 8 0.0003
891 DYSGEUSIA 19 0.0003
892 PERIPHERAL SWELLING 39 0.0003
893 INJECTION SITE BRUISING 20 0.0003
894 METABOLIC ACIDOSIS 8 0.0002
895 JOINT SWELLING 30 0.0002
896 BRADYCARDIA 13 0.0002
897 LIVER INJURY 6 0.0002
898 BALANCE DISORDER 21 0.0002
899 GAIT INABILITY 8 0.0002
900 HALLUCINATION 18 0.0002
901 INTESTINAL OBSTRUCTION 9 0.0002
902 KNEE ARTHROPLASTY 5 0.0002
903 CARDIOVASCULAR DISORDER 6 0.0002
904 BREAST CANCER 22 0.0002
905 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
906 OSTEOARTHRITIS 10 0.0002
907 COGNITIVE DISORDER 11 0.0002
908 JOINT INJURY 5 0.0002
909 RESPIRATORY DISORDER 7 0.0002
910 ERECTILE DYSFUNCTION 6 0.0002
911 DEPRESSION 53 0.0002
912 OCULAR HYPERAEMIA 11 0.0002
913 ECZEMA 12 0.0002
914 EXTRA DOSE ADMINISTERED 9 0.0002
915 FREQUENT BOWEL MOVEMENTS 6 0.0002
916 CHROMATURIA 5 0.0002
917 CRYING 8 0.0002
918 MOOD ALTERED 6 0.0002
919 ANXIETY 62 0.0002
920 TREMOR 36 0.0002
921 POLLAKIURIA 9 0.0002
922 INJECTION SITE PAIN 65 0.0002
923 PRURITUS 81 0.0002
924 BLOOD PRESSURE DECREASED 14 0.0002
925 SPEECH DISORDER 11 0.0002
926 HYPERHIDROSIS 27 0.0002
927 TYPE 2 DIABETES MELLITUS 7 0.0002
928 MUSCULOSKELETAL STIFFNESS 18 0.0002
929 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
930 AGEUSIA 5 0.0002
931 SOMNOLENCE 40 0.0002
932 ABDOMINAL PAIN LOWER 5 0.0002
933 GASTRIC CANCER 5 0.0002
934 OXYGEN SATURATION DECREASED 11 0.0002
935 DRUG ADMINISTRATION ERROR 6 0.0002
936 FEMUR FRACTURE 6 0.0002
937 NO ADVERSE EVENT 35 0.0002
938 SWELLING 18 0.0002
939 NERVOUSNESS 10 0.0002
940 DYSPHAGIA 18 0.0002
941 DEPRESSED MOOD 10 0.0002
942 DRUG INTERACTION 30 0.0002
943 EYE SWELLING 7 0.0002
944 DYSPHONIA 11 0.0002
945 PALPITATIONS 22 0.0002
946 HYPOGLYCAEMIA 9 0.0002
947 ILLNESS 19 0.0002
948 MEMORY IMPAIRMENT 25 0.0002
949 ANAPHYLACTIC REACTION 10 0.0002
950 OVERDOSE 39 0.0002
951 URINARY RETENTION 6 0.0002
952 THROAT IRRITATION 8 0.0002
953 UNDERDOSE 13 0.0002
954 HOT FLUSH 13 0.0002
955 DYSSTASIA 5 0.0002
956 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
958 IRRITABILITY 10 0.0002
959 BLOOD POTASSIUM DECREASED 5 0.0002
960 LACRIMATION INCREASED 5 0.0002
961 EPILEPSY 5 0.0002
962 ANGIOEDEMA 7 0.0002
963 SEIZURE 18 0.0002
964 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
965 NEPHROLITHIASIS 7 0.0002
966 DYSKINESIA 6 0.0001
967 CHEST DISCOMFORT 15 0.0001
968 BLOOD GLUCOSE DECREASED 7 0.0001
969 INJURY 10 0.0001
970 SKIN EXFOLIATION 12 0.0001
971 EYE PAIN 8 0.0001
972 ASTHMA 16 0.0001
973 DRY EYE 7 0.0001
974 THERAPY CESSATION 7 0.0001
975 PRODUCT DOSE OMISSION ISSUE 40 0.0001
976 BLOOD GLUCOSE INCREASED 25 0.0001
977 CHRONIC KIDNEY DISEASE 10 0.0001
978 AGITATION 9 0.0001
979 BLADDER CANCER 7 0.0001
980 ACNE 9 0.0001
981 WHEEZING 7 0.0001
982 DISTURBANCE IN ATTENTION 6 0.0001
983 BLOOD CHOLESTEROL INCREASED 5 0.0001
984 COMA 5 0.0001
985 DRY SKIN 13 0.0001
986 SKIN BURNING SENSATION 6 0.0001
987 TOXICITY TO VARIOUS AGENTS 14 0.0001
988 PRODUCT USE ISSUE 15 0.0001
989 INJECTION SITE REACTION 5 0.0001
990 COMPLETED SUICIDE 5 0.0001
991 PSORIASIS 7 0.0001